These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 10527625

  • 1. Down-regulation of transforming growth factor-beta receptors: cooperativity between the types I, II, and III receptors and modulation at the cell surface.
    Zwaagstra JC, Kassam Z, O'Connor-Mccourt MD.
    Exp Cell Res; 1999 Nov 01; 252(2):352-62. PubMed ID: 10527625
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
    Joyce NC, Harris DL, Mello DM.
    Invest Ophthalmol Vis Sci; 2002 Jul 01; 43(7):2152-9. PubMed ID: 12091410
    [Abstract] [Full Text] [Related]

  • 6. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis.
    Mariano JM, Montuenga LM, Prentice MA, Cuttitta F, Jakowlew SB.
    Int J Dev Biol; 1998 Nov 01; 42(8):1125-36. PubMed ID: 9879710
    [Abstract] [Full Text] [Related]

  • 7. Predominant intracellular localization of the type I transforming growth factor-beta receptor and increased nuclear accumulation after growth arrest.
    Zwaagstra JC, Guimond A, O'Connor-McCourt MD.
    Exp Cell Res; 2000 Jul 10; 258(1):121-34. PubMed ID: 10912794
    [Abstract] [Full Text] [Related]

  • 8. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K, Ahmed MM, Mohiuddin M, Swiderski C, Lee E, Gower WR, Salhab KF, McGrath P, Strodel W, Freeman JW.
    Anticancer Res; 2000 Jul 10; 20(1A):43-51. PubMed ID: 10769633
    [Abstract] [Full Text] [Related]

  • 9. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
    Kubo M, Ihn H, Yamane K, Tamaki K.
    Br J Dermatol; 2006 May 10; 154(5):919-25. PubMed ID: 16634896
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
    Evangelou A, Jindal SK, Brown TJ, Letarte M.
    Cancer Res; 2000 Feb 15; 60(4):929-35. PubMed ID: 10706107
    [Abstract] [Full Text] [Related]

  • 11. Toward an optimum system for intervertebral disc organ culture: TGF-beta 3 enhances nucleus pulposus and anulus fibrosus survival and function through modulation of TGF-beta-R expression and ERK signaling.
    Risbud MV, Di Martino A, Guttapalli A, Seghatoleslami R, Denaro V, Vaccaro AR, Albert TJ, Shapiro IM.
    Spine (Phila Pa 1976); 2006 Apr 15; 31(8):884-90. PubMed ID: 16622376
    [Abstract] [Full Text] [Related]

  • 12. Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells.
    Konrad L, Scheiber JA, Völck-Badouin E, Keilani MM, Laible L, Brandt H, Schmidt A, Aumüller G, Hofmann R.
    BMC Genomics; 2007 Sep 11; 8():318. PubMed ID: 17845732
    [Abstract] [Full Text] [Related]

  • 13. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
    Shariat SF, Menesses-Diaz A, Kim IY, Muramoto M, Wheeler TM, Slawin KM.
    Urology; 2004 Jun 11; 63(6):1191-7. PubMed ID: 15183988
    [Abstract] [Full Text] [Related]

  • 14. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A.
    Biochem J; 2002 Dec 15; 368(Pt 3):683-93. PubMed ID: 12223100
    [Abstract] [Full Text] [Related]

  • 15. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
    Fukuda M, Kurosaki H, Sairenji T.
    J Med Virol; 2006 Nov 15; 78(11):1456-64. PubMed ID: 16998876
    [Abstract] [Full Text] [Related]

  • 16. [Expression of bFGF receptor and TGF-beta receptors in cultured human scleral fibroblasts].
    Qu J, Li H, Zhou XT, Hu DN, Zhang LH, Fu XY, Lü F.
    Zhonghua Yan Ke Za Zhi; 2005 May 15; 41(5):464-7. PubMed ID: 15938815
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K, Sheng H, Shao J, Beauchamp RD.
    Exp Cell Res; 2001 Jun 10; 266(2):239-49. PubMed ID: 11399052
    [Abstract] [Full Text] [Related]

  • 18. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts.
    Dooley S, Delvoux B, Lahme B, Mangasser-Stephan K, Gressner AM.
    Hepatology; 2000 May 10; 31(5):1094-106. PubMed ID: 10796885
    [Abstract] [Full Text] [Related]

  • 19. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y, Zhong X, Uchida I, Koi M, Hemmi H.
    J Cell Physiol; 2001 Jun 10; 187(3):356-64. PubMed ID: 11319759
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.
    Feng XH, Filvaroff EH, Derynck R.
    J Biol Chem; 1995 Oct 13; 270(41):24237-45. PubMed ID: 7592630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.